Showing results (341-350 of 3,750) with videos related to
Sort By:
Pageof 375
Menopause (New York, N.Y.)|June 15, 2011
The risk of squamous cell carcinoma in persistent vulvar ulcersRyan J Spencer, Robert H Young, Annekathryn GoodmanMenopause (New York, N.Y.)|December 4, 2010
Vasomotor menopausal symptoms are associated with increased risk of coronary heart diseaseGerrie-Cor M Gast, Victor J M Pop, Göran N Samsioe, et al.Menopause (New York, N.Y.)|February 4, 2011
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trialGloria Bachmann, Uel Crosby, Robert A Feldman, et al.Menopause (New York, N.Y.)|February 5, 2011
Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal womenC Neill Epperson, Brian Pittman, Kathryn A Czarkowski, et al.Menopause (New York, N.Y.)|February 15, 2011
Symptom interference with work and relationships during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health StudyNancy Fugate Woods, Ellen Sullivan MitchellMenopause (New York, N.Y.)|February 24, 2011
Breast cancer risk assessment: positive predictive value of family history as a predictor of riskRoger P Smith, Xiao Ni, David MuramMenopause (New York, N.Y.)|January 19, 2011
Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone massDébora Castro Gomes, Lúcia Costa-Paiva, Fátima C L G Farhat, et al.Menopause (New York, N.Y.)|January 22, 2011
Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutationsYacine Loucif, Julie Méthot, Karine Tremblay, et al.Menopause (New York, N.Y.)|December 24, 2010
Osteocalcin as a marker of metabolic risk in healthy postmenopausal womenAntonia García-Martín, María Cortés-Berdonces, Inés Luque-Fernández, et al.Menopause (New York, N.Y.)|February 18, 2011
Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitorAnne-Sophie Dieudonné, Johan Vandenberghe, Inge Geerts, et al.Pageof 375